Increased risk of high-grade cervical squamous intraepithelial lesions and invasive cervical cancer among African women with human immunodeficiency virus type 1 and 2 infections

被引:136
作者
Hawes, SE
Critchlow, CW
Niang, MAF
Diouf, MB
Diop, A
Touré, P
Kasse, AA
Dembele, B
Sow, PS
Coll-Seck, AM
Kuypers, JM
Kiviat, NB
机构
[1] Univ Washington, HPV Res Grp, Sch Publ Hlth & Community Med, Dept Epidemiol, Seattle, WA 98103 USA
[2] Univ Washington, Sch Med, Dept Pathol, Seattle, WA 98195 USA
[3] Univ Dakar, Dept Infect Dis, Dakar, Senegal
关键词
D O I
10.1086/376996
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 [免疫学];
摘要
To assess the risk of prevalent high-grade cervical squamous intraepithelial lesions (HSILs) or invasive cervical cancer (ICC) associated with human immunodeficiency virus (HIV) type 1, HIV-2, and human papillomavirus (HPV) infections, HIV load, and CD4 cell count, we studied 4119 women attending an outpatient clinic in Senegal. HIV infection was associated with increased rates of cervical infection with high-risk HPVs. Among women infected with high-risk HPVs, those with HIV-1 (odds ratio [OR], 2.2; 95% confidence interval [CI], 1.0-4.8), HIV-2 (OR, 6.0; 95% CI, 2.1-17.1), or dual HIV infection (OR, 8.0; 95% CI, 2.0-31.5) were more likely to have HSILs or ICC diagnosed than were HIV-negative women; this association was not observed among women not infected with high-risk HPVs. Among women with HIV, higher HIV plasma RNA loads and lower CD4 cell counts were associated with high-risk HPV infection and degree of cervical abnormality. Furthermore, HIV-2-positive women were more likely to have HSILs (OR, 3.3; 95% CI, 0.9-12.4) or ICC (OR, 7.9; 95% CI, 1.1-57) than were HIV-1-positive women.
引用
收藏
页码:555 / 563
页数:9
相关论文
共 80 条
[1]
[Anonymous], 1992, MMWR-MORBID MORTAL W, V41, P1
[2]
PREVALENCE OF HUMAN PAPILLOMAVIRUS IN CERVICAL-CANCER - A WORLDWIDE PERSPECTIVE [J].
BOSCH, FX ;
MANOS, MM ;
MUNOZ, N ;
SHERMAN, M ;
JANSEN, AM ;
PETO, J ;
SCHIFFMAN, MH ;
MORENO, V ;
KURMAN, R ;
SHAH, KV ;
ALIHONOU, E ;
BAYO, S ;
MOKHTAR, HC ;
CHICAREON, S ;
DAUDT, A ;
DELOSRIOS, E ;
GHADIRIAN, P ;
KITINYA, JN ;
KOULIBALY, M ;
NGELANGEL, C ;
TINTORE, LMP ;
RIOSDALENZ, JL ;
SARJADI ;
SCHNEIDER, A ;
TAFUR, L ;
TEYSSIE, AR ;
ROLON, PA ;
TORROELLA, M ;
TAPIA, AV ;
WABINGA, HR ;
ZATONSKI, W ;
SYLLA, B ;
VIZCAINO, P ;
MAGNIN, D ;
KALDOR, J ;
GREER, C ;
WHEELER, C .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1995, 87 (11) :796-802
[3]
Collins N H, 1994, Immunomethods, V5, P189, DOI 10.1006/immu.1994.1055
[4]
Effect of HIV infection on the natural history of anal human papillomavirus infection [J].
Critchlow, CW ;
Hawes, SE ;
Kuypers, JM ;
Goldbaum, GM ;
Holmes, KK ;
Surawicz, CM ;
Kiviat, NB .
AIDS, 1998, 12 (10) :1177-1184
[5]
Screening for cervical cancer [J].
Cuzick, J ;
Meijer, CJLM ;
Walboomers, JMM .
LANCET, 1998, 351 (9113) :1439-1440
[6]
Cervical dysplasia in women infected with the human immunodeficiency virus (HIV): A correlation with HIV viral load and CD4+count [J].
Davis, AT ;
Chakraborty, H ;
Flowers, L ;
Mosunjac, MB .
GYNECOLOGIC ONCOLOGY, 2001, 80 (03) :350-354
[7]
Cervical squamous intraepithelial lesions in HIV-infected women:: prevalence, incidence and regression [J].
Delmas, MC ;
Larsen, C ;
van Benthem, B ;
Hamers, FF ;
Bergeron, C ;
Poveda, JD ;
Anzén, B ;
van den Hoek, A ;
Meier, F ;
Peña, JM ;
Savonius, H ;
Sperandeo, D ;
Suligoi, B ;
Vernazza, P ;
Brunet, JB ;
De Vincenzi, I .
AIDS, 2000, 14 (12) :1775-1784
[8]
Human papillomavirus-associated cervical cytologic abnormalities among women with or at risk of infection with human immunodeficiency virus [J].
Duerr, A ;
Kieke, B ;
Warren, D ;
Shah, K ;
Burk, R ;
Peipert, JF ;
Schuman, P ;
Klein, RS .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2001, 184 (04) :584-590
[9]
Incidence of cervical squamous intraepithelial lesions in HIV-infected women [J].
Ellerbrock, TV ;
Chiasson, MA ;
Bush, TJ ;
Sun, XW ;
Sawo, D ;
Brudney, K ;
Wright, TC .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (08) :1031-1037
[10]
FEINGOLD AR, 1990, J ACQ IMMUN DEF SYND, V3, P896